| Literature DB >> 18455200 |
Manuela Aleku1, Gerald Fisch, Kristin Möpert, Oliver Keil, Wolfgang Arnold, Jörg Kaufmann, Ansgar Santel.
Abstract
Liposomally formulated siRNA can be used for RNAi applications in vivo. Intravenous bolus administration of lipoplexed siRNA has been shown to reduce gene expression in the vascular endothelium. Here, we applied immunofluorescence staining for different endothelial markers (PECAM-1, CD34, laminin) on paraffin sections to compare the respective expression pattern with the intracellular localization of intravenously administered, fluorescently labeled siRNA (siRNA-Cy3-lipoplex). By confocal microscopy, lipoplexed siRNA-Cy3 was detected inside vascular endothelial cells in vivo, which where identified with co-staining of endothelial markers. Consequently, the finding of intracellular siRNA uptake by vascular endothelial cells correlated with RNAi based specific protein reduction in situ as revealed by PECAM-1 specific immunofluorescence staining in lung tissue sections. Therefore, by using a cell biological approach these in situ data emphasize the functional uptake of liposomal siRNA molecules in vascular endothelial cells of different mouse tissues as indicated in our previous molecular study.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18455200 DOI: 10.1016/j.mvr.2008.02.004
Source DB: PubMed Journal: Microvasc Res ISSN: 0026-2862 Impact factor: 3.514